Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythropoietin, the FDA, and oncology.

× No keyword cloud information.

18 in total

1. Home Dialysis in the Prospective Payment System Era.

Authors: Eugene Lin; Xingxing S Cheng; Kuo-Kai Chin; Talhah Zubair; Glenn M Chertow; Eran Bendavid; Jayanta Bhattacharya
Journal: J Am Soc Nephrol Date: 2017-05-10 Impact factor: 10.121

2. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.

Authors: John Bian; Brian Chen; Dawn L Hershman; Norman Marks; LeAnn Norris; Richard Schulz; Charles L Bennett
Journal: J Clin Oncol Date: 2017-04-25 Impact factor: 44.544

3. Medicare coverage for erythropoiesis-stimulating agents: the perfect storm.

Authors:
Journal: Am Health Drug Benefits Date: 2008-05

4. Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study.

Authors: Mariana Chavez-MacGregor; Hui Zhao; Shenying Fang; Tomasz P Srokowski; Gabriel N Hortobagyi; Sharon H Giordano
Journal: Cancer Date: 2011-02-24 Impact factor: 6.860

5. Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.

Authors: Athena T Samaras; Charles L Bennett
Journal: Am J Hematol Oncol Date: 2008-08-01

6. EPO for stroke therapy - Is there a future for further clinical development?

Authors: Jens Minnerup; Heike Wersching; Wolf-Rüdiger Schäbitz
Journal: Exp Transl Stroke Med Date: 2010-05-12

7. Targeting erythroblast-specific apoptosis in experimental anemia.

Authors: Abhinav Diwan; Andrew G Koesters; Devan Capella; Hartmut Geiger; Theodosia A Kalfa; Gerald W Dorn
Journal: Apoptosis Date: 2008-08 Impact factor: 4.677

Review 8. Drug-induced thrombosis: an update.

Authors: Yuval Ramot; Abraham Nyska; Galia Spectre
Journal: Drug Saf Date: 2013-08 Impact factor: 5.606

9. Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents.

Authors: Matthew A Weir; Tara Gomes; Eric Winquist; David N Juurlink; Meaghan S Cuerden; Muhammad Mamdani
Journal: J Oncol Pract Date: 2012-01-17 Impact factor: 3.840

Review 10. Manipulation of the hepcidin pathway for therapeutic purposes.

Authors: Eileen Fung; Elizabeta Nemeth
Journal: Haematologica Date: 2013-11 Impact factor: 9.941